Product › Details

CRISPR gene editing technology

	Next higher product group	nucleic acid editing technology (DNA/RNA-editing technology)
	Status	2013-09-16 use/installation existent
	Organisation	Harvard University
	Original research	Harvard University

Record changed: 2022-05-30

Picture [iito] Fighting Customers 650x100px

More documents for CRISPR gene editing technology

[1] BRAIN Biotech AG. (5/30/22). "Press Release: Ongoing Dynamic Sales Development and Rising Profitability, 6M Reporting". Zwingenberg....
[2] Mammoth Biosciences, Inc.. (1/10/22). "Press Release: Bayer and Mammoth Biosciences to Collaborate on Novel Gene Editing Technology". Berlin & Brisbane, CA....
[3] CRISPR Therapeutics AG. (10/14/21). "Press Release: CRISPR Therapeutics Announces Transition of Chief Financial Officer". Zug & Cambridge, MA....
[4] CRISPR Therapeutics AG. (5/6/21). "Press Release: CRISPR Therapeutics and Nkarta Announce Global Collaboration to Develop Gene-Edited Cell Therapies for Cancer". Zug, Cambridge, MA & South San Francisco, CA....
[5] Twist Bioscience Corporation. (4/28/21). "Press Release: Twist Bioscience and Vivlion Partner to Generate gRNA Libraries for CRISPR Applications". South San Francisco, CA & Frankfurt am Main....
[6] Cytosurge AG. (3/24/21). "Press Release: Cytosurge’s FluidFM Technology Facilitates Multiplex CRISPR Editing and Monoclonal Cell Line Development in less than Three Weeks". Zürich....
[7] Bayer AG. (11/12/20). "Press Release: Metagenomi Closes USD 65 Million Series A Financing Led by Leaps by Bayer and Humboldt Fund". Emeryville, CA & Leverkusen....
[8] CRISPR Therapeutics AG. (10/28/20). "Press Release: CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2020 Financial Results". Zug & Cambridge, MA....
[9] Merck KGaA. (10/12/20). "Press Release: Merck Licenses CRISPR Genome-Editing Technology to PanCELLa and Takara Bio USA". Darmstadt....
[10] ERS Genomics Ltd.. (9/14/20). "Press Release: ERS Genomics Provides Comment on US Patent Office Motions Decisions in CRISPR/Cas9 Interference Case". Dublin....

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]